ATG Fresenius

PreclinicalSmall molecule

UUniversity Hospital, Basel, Switzerland

ATG Fresenius is one of 2 small molecule programs targeting Aplastic Anaemia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Aplastic AnaemiaUnknown status

Aplastic AnaemiaPreclinical

Unknown status

Competition

Competitive Landscape

1 competitor in Aplastic Anaemia

#DrugCompanyPhaseTrials

Nplate

Amgen

Phase 3

1 2

ATG Fresenius

UUniversity Hospital, Basel, Switzerland

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Renal Transplantation2 trials

Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor

Unknown status·RRadboud University Medical Center·Phase 3·NCT00733733·180 enrolled

Comparison of ATG to Thymoglobuline in Renal Transplantation

Completed·UUniversity Hospital, Basel, Switzerland·Phase 4·NCT00861536·40 enrolled

Renal Transplant1 trial

Simulect Versus ATG in Sensitized Renal Transplant Patient

Completed·UUniversity Hospital, Toulouse·Phase 4·NCT02377193·60 enrolled

Aplastic Anaemia1 trial

Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia

Unknown status·NNational Institute of Blood Disease Center, Pakistan·N/A·NCT02028416·60 enrolled

Graft Versus Host Disease1 trial

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Unknown status·FFondazione IRCCS Policlinico San Matteo di Pavia·Phase 3·NCT00934557·42 enrolled

Acute Leukemia1 trial

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Completed·UUniversitätsklinikum Hamburg-Eppendorf·Phase 3·NCT00678275·161 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for ATG Fresenius. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ATG Fresenius compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ATG Fresenius. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Basel, Switzerland company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Basel, Switzerland

ATG Fresenius

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Renal Transplantation2 trials

Renal Transplant1 trial

Aplastic Anaemia1 trial

Graft Versus Host Disease1 trial

Acute Leukemia1 trial

References

Drug Info

Quick Facts

Related News